Literature DB >> 3537032

Histopathologic and immunopathologic study of pyoderma gangrenosum.

W P Su, A L Schroeter, H O Perry, F C Powell.   

Abstract

Sixty-three patients with pyoderma gangrenosum were seen and studied at the Mayo Clinic from 1971 to 1980. Biopsies from the erythematous border or necrotic edge of the pyoderma gangrenosum lesions usually demonstrated a characteristic pathogenic morphologic evolution. The early lesions revealed mild to moderate perivascular lymphocytic infiltrate associated with endothelial swelling. The fully developed lesions demonstrated necrosis in addition to a dense lymphocytic infiltration surrounding as well as involving the blood vessels. Extravasation of erythrocytes and thrombosis sometimes were seen. Ulceration, infarction, and abscess formation were found in the later stages of evolution. Direct immunofluorescence results were positive in the blood vessels of 36 of 65 (55%) specimens. IgM, C3, and fibrin were found in the papillary and reticular dermal vessels. IgG and IgA were only occasionally present. Pyoderma gangrenosum appears to be a reactive process that is manifested as a vasculitis. Biopsy material from the advancing active erythematous border has early characteristic dermatopathologic findings of lymphocytic vasculitis. Cutaneous vascular immune deposits suggest an immune pathogenesis of either an immune complex disease or lymphocytotoxic reaction.

Entities:  

Mesh:

Year:  1986        PMID: 3537032     DOI: 10.1111/j.1600-0560.1986.tb00466.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  27 in total

Review 1.  Unusual causes of cutaneous ulceration.

Authors:  Jaymie Panuncialman; Vincent Falanga
Journal:  Surg Clin North Am       Date:  2010-12       Impact factor: 2.741

Review 2.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

Review 3.  Diagnosis and treatment of pyoderma gangrenosum.

Authors:  Trevor Brooklyn; Giles Dunnill; Chris Probert
Journal:  BMJ       Date:  2006-07-22

4.  Successful treatment of pyoderma gangrenosum associated with juvenile idiopathic arthritis with a combination of topical tacrolimus and oral prednisolone.

Authors:  Pradeep Kumar Shenoy Chandrasekhara; Nambiar Veettil Jayachandran; Joe Thomas; Sumeet Agrawal; Gumdal Narsimulu
Journal:  Clin Rheumatol       Date:  2009-02-03       Impact factor: 2.980

5.  First Report of Pyoderma Gangrenosum after Surgery of Breast Cancer-Related Lymphedema with Transfer of Vascularized Free Lymph Nodes of the Groin and Simultaneous DIEP Flap.

Authors:  Angela A García-Ruano; Esther Deleyto; Jose Maria Lasso
Journal:  Breast Care (Basel)       Date:  2016-02-04       Impact factor: 2.860

6.  Post-traumatic leg ulcer.

Authors:  M R Holbrook; M Doherty; R J Powell
Journal:  Ann Rheum Dis       Date:  1996-04       Impact factor: 19.103

Review 7.  Cutaneous manifestations in systemic vasculitis.

Authors:  I Decleva; A V Marzano; M Barbareschi; E Berti
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

8.  Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation.

Authors:  Carlos A Cañas; Carlos E Durán; Juan C Bravo; Dora E Castaño; Gabriel J Tobón
Journal:  Rheumatol Int       Date:  2010-03-28       Impact factor: 2.631

9.  Refractory skin lesion, hypertension, and acute kidney injury in a young boy: Answers.

Authors:  Valeriya M Feygina; Thomas F Hahn; Dianne G Muchant
Journal:  Pediatr Nephrol       Date:  2017-01-18       Impact factor: 3.714

Review 10.  Effective Strategies for the Management of Pyoderma Gangrenosum.

Authors:  Heidi Goodarzi; Raja K Sivamani; Miki Shirakawa Garcia; Lisa N Wehrli; Hilary Craven; Yoko Ono; Emanual Maverakis
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-10       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.